Cancer is a growing public health challenge across Asia-Pacific and Africa, with the Philippines, South Africa, Australia, and Singapore all experiencing rising incidence of blood cancers, prostate cancer, and haematological disorders. Access to affordable, high-quality oncology medicines remains a critical unmet need across all four markets — one that Indian pharmaceutical manufacturers are uniquely positioned to address.
In Manila and Cebu in the Philippines, blood cancers including leukaemia, lymphoma, and multiple myeloma are increasingly prevalent, yet brand-name treatments like Gleevec, Revlimid, and Velcade are far beyond the reach of most patients. In Johannesburg and Cape Town in South Africa, prostate cancer rates are rising sharply among men over 50, creating urgent demand for affordable Abiraterone (generic Zytiga). In Sydney and Melbourne, Australia, private oncology patients increasingly seek Indian generic alternatives to reduce out-of-pocket costs. And in Singapore, medical tourists and local patients alike seek WHO-approved Indian generics for blood disorders and cancer treatment.
Unnati Pharmax supplies a comprehensive range of anti-cancer medicines to all four markets: Eltrombopag 25mg and 50mg (for ITP and aplastic anaemia), Abiraterone Acetate 250mg (for prostate cancer), Imatinib 400mg (for CML and GIST), Lenalidomide 25mg (for multiple myeloma), and Bortezomib 3.5mg (for myeloma and lymphoma). All products are manufactured in WHO-GMP certified Indian facilities and shipped via DHL/FedEx with full documentation.
For patients, hospital pharmacies, oncology distributors, and NGOs in the Philippines, South Africa, Australia, and Singapore, contact Unnati Pharmax today. Visit medshopy.com or WhatsApp +91 82650 41513 for pricing and international shipping details.
In Manila and Cebu in the Philippines, blood cancers including leukaemia, lymphoma, and multiple myeloma are increasingly prevalent, yet brand-name treatments like Gleevec, Revlimid, and Velcade are far beyond the reach of most patients. In Johannesburg and Cape Town in South Africa, prostate cancer rates are rising sharply among men over 50, creating urgent demand for affordable Abiraterone (generic Zytiga). In Sydney and Melbourne, Australia, private oncology patients increasingly seek Indian generic alternatives to reduce out-of-pocket costs. And in Singapore, medical tourists and local patients alike seek WHO-approved Indian generics for blood disorders and cancer treatment.
Unnati Pharmax supplies a comprehensive range of anti-cancer medicines to all four markets: Eltrombopag 25mg and 50mg (for ITP and aplastic anaemia), Abiraterone Acetate 250mg (for prostate cancer), Imatinib 400mg (for CML and GIST), Lenalidomide 25mg (for multiple myeloma), and Bortezomib 3.5mg (for myeloma and lymphoma). All products are manufactured in WHO-GMP certified Indian facilities and shipped via DHL/FedEx with full documentation.
For patients, hospital pharmacies, oncology distributors, and NGOs in the Philippines, South Africa, Australia, and Singapore, contact Unnati Pharmax today. Visit medshopy.com or WhatsApp +91 82650 41513 for pricing and international shipping details.